Juan Vivanco-Suarez, Mahmoud Dibas, Demetrius Klee Lopes, Ricardo A Hanel, Mario Martínez-Galdámez, Aaron Rodriguez-Calienes, Gustavo M Cortez, Johanna T Fifi, Alex Devarajan, Gabor Toth, Thomas Patterson, David Altschul, Vitor M Pereira, Eileen Liu, Ajit S Puri, Anna Luisa Kuhn, Waldo R Guerrero, Priyank Khandelwal, Ivo Bach, Peter Kan, Gautam Edhayan, Curtis Given, Sandra Narayanan, Bradley A Gross, Mudassir Farooqui, Milagros Galecio-Castillo, Shahram Derakhshani, Santiago Ortega-Gutierrez
BACKGROUND: Flow diverters are the first-line treatment for specific intracranial aneurysms (iA). Surpass Evolve (SE) is a new-generation 64-wire flow diverter with a high braid angle. Current literature on the SE is limited. We aimed to report the first international real-world experience evaluating the safety and effectiveness of the SE. METHODS: The Safety and Effectiveness Assessment of the Surpass Evolve (SEASE) was a multicenter retrospective international post-marketing cohort study including consecutive patients treated with SE for iAs between 2020 and 2022...
April 25, 2024: Journal of Neurointerventional Surgery